17 research outputs found

    Spectrum Orbit Utilization Program Documentation: SOUP5 Version 3.8 User's Manual, Volume 2, Appendices a Through G

    Get PDF
    The appendixes of the user manual are presented. Input forms which may be used to prepare data for the SOUP5V3.4 of the R2BCSAT-83 data base are given. The IBM job control language which can be used to run the SOUP5 system from a magnetic tape is described. Copies of a run using the delivered tape and IBM OS/MVS Job Control Language card deck are illustrated. Numerical limits on scenario data requests are listed. Error handling, error messages and editing procedures are also listed. Instructions as to how to enter a protection ratio template are given. And relation between PARC prameter, channelization, channel families, and interference categories are also listed

    Anti-Müllerian hormone in PCOS: a review informing international guidelines

    Get PDF
    Polycystic ovary syndrome (PCOS) affects 8-13% of women. The Rotterdam diagnostic criteria include polycystic ovarian morphology (PCOM) on ultrasound, but given recognized challenges, serum anti-Müllerian hormone (AMH) is proposed as an alternative. To inform international PCOS guidelines, a systematic review was completed. Key identified gaps include large international studies in well-defined populations across the lifespan, clustering of AMH with PCOS features, relationships to long-term health outcomes, and improved quality, assay standardization, and sample handling, all needed to determine cut offs. Here we identify research priorities to address these gaps and enhance AMH utility in PCOS. Once issues are addressed, AMH levels could replace more costly and less accessible ultrasound in PCOS diagnosis.Helena Teede, Marie Misso, Eliza C.Tassone, Didier Dewailly, Ernest HyNg, Ricardo Azziz ... Robert J.Norman ... et al

    Attitudes and self-reported behavior of patients, doctors, and pharmacists in New Zealand and Belgium toward direct-to-consumer advertising of medication

    No full text
    Patients', doctors', and pharmacists' attitudes toward direct-to-consumer advertising (DTCA) for medication and their perceptions of its impact on patient self-reported behavior in terms of request for, and consumption of, advertised medication were investigated. Data were obtained in New Zealand, 1 of only 2 countries that allow mass-media DTCA for prescription medication, and in Belgium, which does not. Attitudes were relatively negative in both countries, but significantly more positive in New Zealand than in Belgium. The impact of DTCA (both in a positive and a negative sense) on self-reported patient behavior and patient interaction with doctors and pharmacists was limited in both countries. Although - as already established in previous work - the informativeness and reliability of DTCA can be much improved, and the attitude of medical professionals toward DTCA is negative in both countries, from the point of view of medical professionals and patients, DTCA does not harm the self-reported relationship between doctors, pharmacists, and patients
    corecore